Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.
OBJECTIVE
To investigate the effects of prolonged hyperoxia on vascular recovery and glia survival after experimentally induced retinopathy of prematurity (ROP) in the mouse.


METHODS
The effects of hyperoxia on revascularization and vitreous neovascularization were compared between mice raised in 75% oxygen from postnatal day (P)7 to P12, followed by room air recovery and mice raised in 75% oxygen from P7 to P27. The status of astrocytes and Müller cells was evaluated by glial fibrillary acidic protein (GFAP) immunohistochemistry on retinal wholemounts and serial sections. A window of susceptibility to oxygen-induced vaso-obliteration was defined by comparing the extent of retinal vaso-obliteration resulting from 2 days of hyperoxia beginning on P7, P9, P11, P13, or P15.


RESULTS
Oxygen-induced vaso-obliteration of retinal capillaries was limited to the period between birth and P15. Paradoxically, revascularization was markedly accelerated and neovascularization markedly reduced in mice maintained in prolonged hyperoxia (P7-P27) compared with mice recovering in room air. The extended use of 75% oxygen during the recovery period was associated with preservation of astrocytes and Müller cells in the avascular retina.


CONCLUSIONS
The antiangiogenic effect of hyperoxia on retinal capillaries is strongly dependent on postnatal age. A protocol of continuous 75% supplemental oxygen accelerates recovery of inner retinal vasculature and prevents vitreous neovascularization, by a mechanism that may involve preservation of inner retinal glia.
Gu
Xiaolin
X
Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta, Georgia, USA.
Samuel
Sara
S
El-Shabrawey
Mohamed
M
Caldwell
Ruth B
RB
Bartoli
Manuela
M
Marcus
Dennis M
DM
Brooks
Steven E
SE
D000818:Animals; D004195:Disease Models, Animal; D019084:Fluorescent Antibody Technique, Indirect; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006801:Humans; D018496:Hyperoxia / Q000150:complications* / Q000473:pathology; D007231:Infant, Newborn; D051379:Mice; D008810:Mice, Inbred C57BL; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000473:pathology / Q000517:prevention & control; D009457:Neuroglia / Q000378:metabolism / Q000473:pathology; D012008:Recurrence; D015861:Retinal Neovascularization / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D012171:Retinal Vessels / Q000473:pathology; D012178:Retinopathy of Prematurity / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D013997:Time Factors; D014822:Vitreous Body / Q000098:blood supply*
D005904:Glial Fibrillary Acidic Protein